LXRX — Lexicon Pharmaceuticals, Inc. stock price, charts and financials

QT78Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
2.45
-0.02-0.81%
OverviewShort InterestFilings
LXRXQT78Lexicon Pharmaceuticals, Inc.·NASDAQ
2.45-0.81%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 2026S-8Registration of employee benefit securities
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 06, 2026S-3Shelf registration statement
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
Apr 30, 20268-KCurrent report
#1 / 25 of 358
Page
▼
/ 15